Versameb at Sachs 21st Annual Biotech in Europe Forum

• Isabel Ferreira speaking on the “Platform Technologies and Novel Therapeutics” Panel

Versameb AG (“Versameb”), a pre-clinical stage company focused on discovering and developing innovative RNA-based drugs, today announces its participation in the  21^st Annual Biotech in Europe Forum organized by SACHS Associates taking place virtually 7^th-8^th October 2021.

Read more…